Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimethoprim-sulfamethoxazole for Recurrent Ocular Toxoplasmosis
NCT01449877Phase 3Completed
- Sponsor
- Universidade Estadual de Campinas
- Start
- Oct 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ocular toxoplasmosis comparing Trimethoprim-Sulfamethoxazole with Placebo (2 arms). Primary endpoint: Incidence of episodes of recurrent chorioretinitis by toxoplasmosis at 120 months. Started Oct 2011; status: completed.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
ocular toxoplasmosis
Beyond the preview
Go deeper on NCT01449877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01449877.